VRDN compared with CLDX: revenue, margins and what each company keeps, and the suppliers and customers both name

VRDNViridian Therapeutics, Inc.

Mkt capRevenueRevenue

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

VRDNViridian Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VRDN 8

ZLABZai Labsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

—Zenas BioPharmaunlistedsupplier

—ImmunoGenunlistedsupplier

4 more · VRDN chain ›

Shared 0

No shared counterparties.

Only CLDX 1

—Rockefeller Universityunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

VRDNViridian Therapeutics, Inc.

25.29· pre 25.29· delayed

Mkt cap$2.8BRevenue$284,000Q2 FY26Revenue$71MFY25

CLDXCelldex Therapeutics, Inc.

29.04· pre 29.81· delayed

Pre-marketNov 3 '26delayed

Mkt cap$2.3BRevenue$22,000Q2 FY26Revenue$7MFY24

Compare

Pre-marketNov 3 '26delayed

VRDNViridian Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

25.29pre 25.29delayed

Price

29.04pre 29.81delayed

$2.8B

Mkt cap

$2.3B

Q2 FY26$284,000

Revenue

$22,000Q2 FY26

FY25$71M

Revenue

$7MFY24

VRDN25.29vsCLDX29.04Pre-marketNov 3 '26delayed